Clinical and immunologic predictors of influenza illness among vaccinated older adults

Vaccine

Volumn 28, Issue 38, 2010, Pages 6145-6151

  Shahid, Zainab ^a   Kleppinger, Alison ^a   Gentleman, Beth ^b   Falsey, Ann R ^c   McElhaney, Janet E ^a,b  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Elderly; Granzyme B; Influenza; Interferon ; Interleukin 10

Indexed keywords

GAMMA INTERFERON; GRANZYME B; INTERLEUKIN 10;

ADULT; AGED; ANTIBODY TITER; ARTICLE; CELLULAR IMMUNITY; CLINICAL FEATURE; COHORT ANALYSIS; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DISEASE SEVERITY; ELDERLY CARE; FEMALE; FEVER; FLU LIKE SYNDROME; HUMAN; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A H3N2; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; CELLS, CULTURED; FEMALE; FEVER; GRANZYMES; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; IMMUNITY, CELLULAR; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; INTERFERON-GAMMA; INTERLEUKIN-10; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; ODDS RATIO; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 77955665631     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.07.036     Document Type: Article

References (22)

1. Thompson W.W., Shay D.K., Weintraub E., Brammer L., Cox N., Anderson L.J., et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003, 289(2):179-186.
2. Thompson W.W., Shay D.K., Weintraub E., Brammer L., Bridges C.B., Cox N.J., et al. Influenza-associated hospitalizations in the United States. JAMA 2004, 292(11):1333-1340.
3. Glezen W.P. Serious morbidity and mortality associated with influenza epidemics. Epidemiol Rev 1982, 4:25-44.
4. Carrat F., Tachet A., Rouzioux C., Housset B., Valleron A.J. Evaluation of clinical case definitions of influenza: detailed investigation of patients during the 1995-1996 epidemic in France. Clin Infect Dis 1999, 28(2):283-290.
5. van Elden L.J., van Essen G.A., Boucher C.A., van Loon A.M., Nijhuis M., Schipper P., et al. Clinical diagnosis of influenza virus infection: evaluation of diagnostic tools in general practice. Br J Gen Pract 2001, 51(469):630-634.
6. McMichael A.J., Gotch F.M., Noble G.R., Beare P.A. Cytotoxic T-cell immunity to influenza. N Engl J Med 1983, 309(1):13-17.
7. Pawelec G., Akbar A., Caruso C., Solana R., Grubeck-Loebenstein B., Wikby A. Human immunosenescence: is it infectious?. Immunol Rev 2005, 205(June):257-268.
8. Johnson B.J., Costelloe E.O., Fitzpatrick D.R., Haanen J.B., Schumacher T.N., Brown L.E., et al. Single-cell perforin and granzyme expression reveals the anatomical localization of effector CD8+ T cells in influenza virus-infected mice. Proc Natl Acad Sci U S A 2003, 100(5):2657-2662. [Epub 003 Feb 24].
9. Lawrence C.W., Ream R.M., Braciale T.J. Frequency, specificity, and sites of expansion of CD8+ T cells during primary pulmonary influenza virus infection. J Immunol 2005, 174(May(9)):5332-5340.
10. Ewen C., Kane K.P., Shostak I., Griebel P.J., Bertram E.M., Watts T.H., et al. A novel cytotoxicity assay to evaluate antigen-specific CTL responses using a colorimetric substrate for Granzyme B. J Immunol Methods 2003, 276(1-2):89-101.
11. McElhaney J.E., Pinkoski M.J., Upshaw C.M., Bleackley R.C. The cell-mediated cytotoxic response to influenza vaccination using an assay for granzyme B activity. J Immunol Methods 1996, 190(1):11-20.
12. HO Collaborating Center for Influenza BPD The hemagglutination inhibition test for influenza viruses 1981, DHEW, PHS, CDC, Center for Infectious Disease, revised, Atlanta (GA), pp. 1-21.
13. McElhaney J.E., Ewen C., Zhou X., Kane K.P., Xie D., Hager W.D., et al. Granzyme B: correlates with protection and enhanced CTL response to influenza vaccination in older adults. Vaccine 2009, 27:2418-2425.
14. McElhaney J.E., Xie D., Hager W.D., Barry M.B., Wang Y., Kleppinger A., et al. T cell responses are better correlates of vaccine protection in the elderly. J Immunol 2006, 176(May(10)):6333-6339.
15. Gijzen K., Liu W.M., Visontai I., Oftung F., van der Werf S., Korsvold G.E., et al. Standardization and validation of assays determining cellular immune responses against influenza. Vaccine 2010, 28(19):3416-3422.
16. Leng S.X., McElhaney J.E., Walston J.D., Xie D., Fedarko N.S., Kuchel G.A. ELISA and multiplex technologies for cytokine measurement in inflammation and aging research. J Gerontol A: Biol Sci Med Sci 2008, 63(August(8)):879-884.
17. Govaert T.M., Dinant G.J., Aretz K., Knottnerus J.A. The predictive value of influenza symptomatology in elderly people. Fam Pract 1998, 15(1):16-22.
18. Monto A.S., Gravenstein S., Elliott M., Colopy M., Schweinle J. Clinical signs and symptoms predicting influenza infection. Arch Intern Med 2000, 160(21):3243-3247.
19. Heilly S.J., Janoff E.N., Nichol P., Nichol K.L. Rapid diagnosis of influenza infection in older adults: influence on clinical care in routine clinical setting. J Clin Virol 2008, 42:124-128.
20. Nicholson K.G., Kent J., Hammersley V., Cancio E. Acute viral infections of upper respiratory tract in elderly people living in the community: comparative, prospective, population based study of disease burden. BMJ 1997, 315(7115):1060-1064.
21. Boivin G., Hardy I., Tellier G., Maziade J. Predicting influenza infections during epidemics with use of a clinical case definition. Clin Infect Dis 2000, 31(5):1166-1169. [Epub 2000 Nov 06].
22. McElhaney J.E., Gravenstein S., Krause P., Hooton J.W., Upshaw C.M., Drinka P. Assessment of markers of the cell-mediated immune response after influenza virus infection in frail older adults. Clin Diagn Lab Immunol 1998, 5(6):840-844.